Author:
Hasan Mohammad R.,Ho Shirley H. Y.,Owen David A.,Tai Isabella T.
Reference23 articles.
1. Irinotecan and 5-fluorouracil in colorectal cancer: time for a pause?;Bulusu;Eur J Cancer,1998
2. FDA drug approval summary: bevacizumab plus FOLFOX4 as second-line treatment of colorectal cancer;Cohen;Oncologist,2007
3. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer;Hurwitz;N Engl J Med,2004
4. Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders;Presta;Cancer Res,1997
5. Molecular regulation of tumor angiogenesis: mechanisms and therapeutic implications;Harper;EXS,2006
Cited by
61 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献